Fusarochromanone is an inhibitor of melanoma growth. References: El-Saadi MW, Williams-Hart T, Salvatore BA, Mahdavian E. Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent. In Silico Pharmacol. 2015 Dec;3(1):6. doi: 10.1186/s40203-015-0010-5. Epub 2015 Jun 4. PubMed PMID: 26820891; PubMed Central PMCID: PMC4464579.

纯度：≥98%

CAS：802915-53-3